We continue to be very enthusiastic about a product pipeline and encouraged by the feedback we are receiving from physicians. Next month, we will highlight the pipeline at the Annual (inaudible) conference in New York including presentation on AFX, PEVAR, Nellix, and Ventana. We also expect to have new articles published over the next year and just recently had an AFX initial case experience published in endovascular today.Read the rest of this transcript for free on seekingalpha.com
Endologix's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.